# Cephalogics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cephalogics

- Industry: Medical Devices & Equipment
- Headquarters: Boston, US
- Website: www.alliedminds.com/subsidiaries/cephalogics
- Total disclosed funding: $0.5M
- Latest round: Seed (Jan 21, 2007)
- Investors on record: 1

## About

Cephalogics is focused on transforming academic and government research into innovative medical solutions. The company specializes in developing advanced technologies aimed at improving healthcare diagnostics and treatment options through rigorous scientific research.Cephalogics, founded in 2007, is a company dedicated to creating effective medical solutions derived from scientific research. The company is based in Boston, US, and has successfully completed two significant deals since its inception, with the most recent deal occurring on December 21, 2010. Cephalogics received a grant of USD 0.160 mn from the National Institutes of Health under the Qualifying Therapeutic Discovery Project program. The total amount raised by the company amounts to USD 0.500 mn.Cephalogics focuses on transforming academic breakthroughs and U.S. government research into innovative commercial products. The company's offerings are primarily centered around advanced technologies derived from scientific research, addressing various industry challenges in the healthcare sector. Their products serve diverse markets, enhancing operational efficiency and improving diagnostics, while collaborating closely with academic institutions and government entities to identify promising technologies.Cephalogics generates revenue through strategic partnerships and direct sales of its patented technologies. The company engages in business-to-business transactions, providing advanced solutions to healthcare entities and government agencies. Revenue streams include licensing agreements, collaborative research partnerships, and commercialization of products developed from government-funded research initiatives.Cephalogics is committed to expanding its product line with new healthcare solutions, leveraging the recent grant funding to accelerate research and development. The company aims to target new markets in North America and Europe by 2025, which will allow them to broaden their reach and enhance their impact in the healthcare industry. The funding received is intended to support ongoing projects and develop new offerings that address specific healthcare challenges.

## Funding rounds

- Seed, Jan 21, 2007, $0.5M — Allied Minds

## Investors

- Allied Minds (https://capitalatlas.ai/funds/allied-minds) — Seed